Cancer Research Institute (CRI) shared a post on LinkedIn:
“‘The CRI Technology Impact Award is a perfect example of bringing together new technologies with the problem of getting cancer immunotherapy to work. Having a foundation willing to take a bet early on – when the science is not yet ready to be employed widely, but where early discoveries can really move the needle – that is often research that is hard to fund, because it is very risky,’ emphasizes CRI Tech Impact Award grantee Dr. Karin Pelka at Gladstone Institutes.
During March’s Colorectal Cancer Awareness Month, discover how Dr. Pelka is fine-tuning immunotherapy for colorectal cancer by listening in on the molecular conversations happening inside the tumor itself.
Proceed to video attached to the post.”
Other articles about Cancer Research Institute on OncoDaily.